Cargando…
Human Tissue Angiotensin Converting Enzyme (ACE) Activity Is Regulated by Genetic Polymorphisms, Posttranslational Modifications, Endogenous Inhibitors and Secretion in the Serum, Lungs and Heart
Objective: Inhibitors of the angiotensin converting enzyme (ACE) are the primarily chosen drugs to treat heart failure and hypertension. Moreover, an imbalance in tissue ACE/ACE2 activity is implicated in COVID-19. In the present study, we tested the relationships between circulating and tissue (lun...
Autores principales: | Bánhegyi, Viktor, Enyedi, Attila, Fülöp, Gábor Áron, Oláh, Attila, Siket, Ivetta Mányiné, Váradi, Csongor, Bottyán, Klaudia, Lódi, Mária, Csongrádi, Alexandra, Umar, Azeem J., Fagyas, Miklós, Czuriga, Dániel, Édes, István, Pólos, Miklós, Merkely, Béla, Csanádi, Zoltán, Papp, Zoltán, Szabó, Gábor, Radovits, Tamás, Takács, István, Tóth, Attila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305685/ https://www.ncbi.nlm.nih.gov/pubmed/34359878 http://dx.doi.org/10.3390/cells10071708 |
Ejemplares similares
-
Changes in the SARS-CoV-2 cellular receptor ACE2 levels in cardiovascular patients: a potential biomarker for the stratification of COVID-19 patients
por: Fagyas, Miklós, et al.
Publicado: (2021) -
New Perspectives in the Renin-Angiotensin-Aldosterone System (RAAS) IV: Circulating ACE2 as a Biomarker of Systolic Dysfunction in Human Hypertension and Heart Failure
por: Úri, Katalin, et al.
Publicado: (2014) -
Prophylactic, single-drug cardioprotection in a comparative, experimental study of doxorubicin-induced cardiomyopathy
por: Lódi, Mária, et al.
Publicado: (2020) -
Level of the SARS-CoV-2 receptor ACE2 activity is highly elevated in old-aged patients with aortic stenosis: implications for ACE2 as a biomarker for the severity of COVID-19
por: Fagyas, Miklós, et al.
Publicado: (2021) -
New Perspectives in the Renin-Angiotensin-Aldosterone System (RAAS) I: Endogenous Angiotensin Converting Enzyme (ACE) Inhibition
por: Fagyas, Miklós, et al.
Publicado: (2014)